Independent French drugmaker Servier, which is governed by a foundation, has published its 2023/24 financial year results and ...

Servier is paying $1.8 billion upfront for ... Cancer is a key area for the French company, which sells products like Pixuvri (pixantrone) for non-Hodgkin lymphoma (NHL) and colorectal cancer ...

Servier is paying $1.8 billion upfront for ... Cancer is a key area for the French company, which sells products like Pixuvri (pixantrone) for non-Hodgkin lymphoma (NHL) and colorectal cancer ...

Servier to leverage Google Cloud AI across ... We sell different types of products and services to both investment professionals and individual investors. These products and services are usually ...

Some six and a half years since its debut, Servier’s U.S. arm has made good on its oncology growth ambitions while managing to stay true to its patient-centric ethos along the way. | Some six and a ...

The Arklow & District Chamber of Commerce has thanked local pharmaceutical company Servier for hosting their recent chamber ...

Servier to leverage Google Cloud AI across R&D, production, and distribution, accelerating digital transformation to benefit patients. These new advancements in artificial intelligence and ...

Servier India Pvt. Ltd. has launched a single-pill combination (SPC) of Bisoprolol/Perindopril in India under the brand name ...

Servier is extending its pact with Google Cloud as the French biopharma points to 60 examples of how generative artificial intelligence could improve its drug development processes. The two ...

Servier to leverage Google Cloud AI across R&D, production, and distribution, accelerating digital transformation to benefit patients. These new advancements in artificial intelligence and generative ...